• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIF-1α 抑制剂 YC-1 及其衍生物抗肿瘤研究进展。

Advances in antitumor research of HIF-1α inhibitor YC-1 and its derivatives.

机构信息

Institute of Pharmacy and Pharmacology, Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hengyang Medicial School, University of South China, Hengyang, Hunan 421001, China.

The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China.

出版信息

Bioorg Chem. 2023 Apr;133:106400. doi: 10.1016/j.bioorg.2023.106400. Epub 2023 Jan 30.

DOI:10.1016/j.bioorg.2023.106400
PMID:36739684
Abstract

Generally, hypoxia-inducible factor-1α (HIF-1α) is highly expressed in solid tumors, it plays a key role in the occurrence and development of tumors, hindering cancer treatment in various ways. The antitumor activity and pharmacological mechanism of YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1‑benzyl indazole], an HIF-1α inhibitor, and the design and synthesis of its derivatives have attracted tremendous attention in the field of antitumor research. YC-1 is a potential drug candidate and a lead compound for tumor therapy. Hence, the multifaceted mechanism of action of YC-1 and the structure activity relationship (SAR) of its derivatives are important factors to be considered for the development of HIF-1α inhibitors. Therefore, this review aimed to provide a comprehensive overview of the various antitumor mechanisms of YC-1 in antitumor research and an in-depth summary of the SAR for the development of its derivatives. A full understanding and discussion of these aspects are expected to provide potential ideas for developing novel HIF-1α inhibitors and antitumor drugs belonging to the YC-1 class. The review also highlighted the application prospects of the YC-1 class of potential antitumor candidates, and provided some unique insights about these antitumor agents.

摘要

一般来说,缺氧诱导因子-1α(HIF-1α)在实体瘤中高度表达,它在肿瘤的发生和发展中起着关键作用,以各种方式阻碍癌症治疗。YC-1(3-(5'-羟甲基-2'-呋喃基)-1-苄基吲唑)是一种 HIF-1α抑制剂,其抗肿瘤活性和药理学机制及其衍生物的设计和合成在抗肿瘤研究领域引起了极大的关注。YC-1是一种有潜力的药物候选物和肿瘤治疗的先导化合物。因此,YC-1的多方面作用机制及其衍生物的构效关系(SAR)是开发 HIF-1α抑制剂的重要考虑因素。因此,本综述旨在全面概述 YC-1 在抗肿瘤研究中的各种抗肿瘤机制,并深入总结其衍生物的 SAR。全面理解和讨论这些方面有望为开发新型 HIF-1α抑制剂和属于 YC-1 类的抗肿瘤药物提供潜在思路。该综述还强调了 YC-1 类潜在抗肿瘤候选物的应用前景,并对这些抗肿瘤药物提供了一些独特的见解。

相似文献

1
Advances in antitumor research of HIF-1α inhibitor YC-1 and its derivatives.HIF-1α 抑制剂 YC-1 及其衍生物抗肿瘤研究进展。
Bioorg Chem. 2023 Apr;133:106400. doi: 10.1016/j.bioorg.2023.106400. Epub 2023 Jan 30.
2
Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.YC-1对缺氧人膀胱移行癌细胞系T24细胞中缺氧诱导因子1α的影响。
Urol Int. 2012;88(1):95-101. doi: 10.1159/000331881. Epub 2011 Oct 25.
3
Suppression of hypoxia inducible factor-1alpha (HIF-1alpha) by YC-1 is dependent on murine double minute 2 (Mdm2).YC-1对缺氧诱导因子-1α(HIF-1α)的抑制作用依赖于小鼠双微体2(Mdm2)。
Biochem Biophys Res Commun. 2006 Oct 6;348(4):1443-8. doi: 10.1016/j.bbrc.2006.08.015. Epub 2006 Aug 11.
4
YC-1 sensitizes the antitumor effects of boron neutron capture therapy in hypoxic tumor cells.YC-1 增强硼中子俘获治疗在缺氧肿瘤细胞中的抗肿瘤效应。
J Radiat Res. 2020 Jul 6;61(4):524-534. doi: 10.1093/jrr/rraa024.
5
A domain responsible for HIF-1alpha degradation by YC-1, a novel anticancer agent.一个由新型抗癌药物YC-1负责HIF-1α降解的结构域。
Int J Oncol. 2006 Jul;29(1):255-60.
6
Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells.YC-1对缺氧诱导因子1驱动的转录活性、人胰腺癌细胞在缺氧状态下的增殖活力及凋亡的影响。
Pancreas. 2007 Mar;34(2):242-7. doi: 10.1097/01.mpa.0000250135.95144.b6.
7
YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.YC-1抑制前列腺癌细胞中HIF-1的表达:缺氧时Akt/NF-κB信号传导对HIF-1α积累的作用。
Oncogene. 2007 Jun 7;26(27):3941-51. doi: 10.1038/sj.onc.1210169. Epub 2007 Jan 8.
8
YC-1 exerts inhibitory effects on MDA-MB-468 breast cancer cells by targeting EGFR in vitro and in vivo under normoxic condition.在常氧条件下,体外和体内实验中,YC-1通过靶向表皮生长因子受体(EGFR)对MDA-MB-468乳腺癌细胞发挥抑制作用。
Chin J Cancer. 2012 May;31(5):248-56. doi: 10.5732/cjc.011.10383. Epub 2012 Apr 13.
9
Effects of YC-1 targeting hypoxia-inducible factor 1 alpha in oesophageal squamous carcinoma cell line Eca109 cells.靶向低氧诱导因子 1α 的 YC-1 对食管鳞癌细胞系 Eca109 细胞的影响。
Cell Biol Int. 2011 May;35(5):491-7. doi: 10.1042/CBI20090419.
10
The effect of 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole (YC-1) on cell viability under hypoxia.3-(5'-羟甲基-2'-呋喃基)-1-苄基吲唑(YC-1)对缺氧条件下细胞活力的影响。
Mol Vis. 2013 Nov 16;19:2260-73. eCollection 2013.

引用本文的文献

1
ROS-Responsive Nanosystem Targeted Co-Delivery YC-1 and Regorafenib to Alleviate Hypoxia Enhancing Hepatocellular Carcinoma Therapy.ROS响应性纳米系统靶向共递送YC-1和瑞戈非尼以减轻缺氧并增强肝细胞癌治疗效果
Int J Nanomedicine. 2025 Jul 1;20:8481-8496. doi: 10.2147/IJN.S518120. eCollection 2025.
2
Effects of serum HIF-1α, VEGF, and uPA levels on clinicopathologic findings and prognosis in oral squamous cell carcinoma.血清缺氧诱导因子-1α、血管内皮生长因子和尿激酶型纤溶酶原激活剂水平对口腔鳞状细胞癌临床病理特征及预后的影响
Int J Clin Exp Pathol. 2025 Jan 15;18(1):12-22. doi: 10.62347/CXDC6773. eCollection 2025.
3
EZH2 suppresses IR-induced ferroptosis by forming a co-repressor complex with HIF-1α to inhibit ACSL4: Targeting EZH2 enhances radiosensitivity in KDM6A-deficient esophageal squamous carcinoma.
EZH2通过与HIF-1α形成共抑制复合物来抑制铁死亡诱导因子(IR)诱导的铁死亡,从而抑制ACSL4:靶向EZH2可增强KDM6A缺陷型食管鳞状细胞癌的放射敏感性。
Cell Death Differ. 2025 Feb 7. doi: 10.1038/s41418-025-01451-5.
4
Ginseng glucosyl oleanolate inhibit cervical cancer cell proliferation and angiogenesis via PI3K/AKT/HIF-1α pathway.人参葡萄糖基齐墩果酸酯通过PI3K/AKT/HIF-1α通路抑制宫颈癌细胞增殖和血管生成。
NPJ Sci Food. 2024 Dec 19;8(1):105. doi: 10.1038/s41538-024-00341-3.
5
Network pharmacology and experimental evaluation strategies to decipher the underlying pharmacological mechanism of Traditional Chinese Medicine CFF-1 against prostate cancer.网络药理学与实验评价策略解析中药 CFF-1 抗前列腺癌的潜在作用机制。
Aging (Albany NY). 2024 Mar 13;16(6):5387-5411. doi: 10.18632/aging.205654.
6
Inhibition of OGFOD1 by FG4592 confers neuroprotection by activating unfolded protein response and autophagy after ischemic stroke.FG4592 通过抑制 OGFOD1 激活未折叠蛋白反应和自噬从而在缺血性脑卒中后发挥神经保护作用。
J Transl Med. 2024 Mar 7;22(1):248. doi: 10.1186/s12967-024-04993-3.
7
Reprogramming of regulatory T cells in inflammatory tumor microenvironment: can it become immunotherapy turning point?在炎症性肿瘤微环境中重新编程调节性 T 细胞:它能成为免疫治疗的转折点吗?
Front Immunol. 2024 Feb 21;15:1345838. doi: 10.3389/fimmu.2024.1345838. eCollection 2024.